CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax of -$6.87 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax · last filed 2026-02-17
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax for fiscal 2025 was -$6.87M, a 224.45% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax for fiscal 2024 was $5.52M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax for fiscal 2023 was -$3.14M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax for fiscal 2022 was -$1.53M, a 112.09% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax 12 month |
|---|---|
| 2025-12-31 | -$6.87M 10-K · filed 2026-02-17 |
| 2024-12-31 | $5.52M 10-K · filed 2026-02-17 |
| 2023-12-31 | -$3.14M 10-K · filed 2026-02-17 |
| 2022-12-31 | -$1.53M 10-K · filed 2025-02-18 |
| 2021-12-31 | $12.66M 10-K · filed 2024-02-28 |
| 2020-12-31 | -$8.49M 10-K · filed 2023-02-21 |
| 2019-12-31 | -$4.74M 10-K · filed 2022-02-22 |
| 2018-12-31 | $10.98M 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |